Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

GE Healthcare

Nov 2011
GE Healthcare of Chalfont St. Giles, UK, is set to dedicate $1 billion of its total R&D budget over the next five years to expanding its advanced cancer diagnostic and molecular imaging capabilities as well as its technologies for biopharmaceuticals manufacturing and for cancer research. Announced alongside a $100 million open innovation challenge in New York, the billion-dollar investment crosses all lines of GE Healthcare’s global business and will enable the company to bring the most promising cancer ideas to market. The company’s solutions combine medical imaging, molecular diagnostics and health care information technology.

AmericasBiophotonicsBusinesscancer diagnosticscancer researchEnglandEuropeGE HealthcareimagingindustrialJohn Dineenlaboratory diagnosticsmedical imagingmolecular imagingNew YorkoncologyR&D expendituresRapidScan

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!